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Background: Evidence of the effectiveness of printed educational messages in narrowing the gap between
guideline recommendations and practice is contradictory. Failure to screen for retinopathy exposes primary care
patients with diabetes to risk of eye complications. Screening is initiated by referral from family practitioners but
adherence to guidelines is suboptimal. We aimed to evaluate the ability of printed educational messages aimed at
family doctors to increase retinal screening of primary care patients with diabetes.
Methods: Design: Pragmatic 2×3 factorial cluster trial randomized by physician practice, involving 5,048 general
practitioners (with 179,833 patients with diabetes). Setting: Ontario family practitioners. Interventions: Reminders
(that retinal screening helps prevent diabetes-related vision loss and is covered by provincial health insurance for
patients with diabetes) with prompts to encourage screening were mailed to each physician in conjunction with a
widely-read professional newsletter. Alternative printed materials formats were an ‘outsert’ (short, directive message
stapled to the outside of the newsletter), and/or a two-page, evidence-based article (‘insert’) and a pre-printed sticky
note reminder for patients. Main outcome measure: A successful outcome was an eye examination (which includes
retinal screening) provided to a patient with diabetes, not screened in the previous 12 months, within 90 days after
visiting a family practitioner. Analysis accounted for clustering of doctors within practice groups.
Results: No intervention effect was detected (eye exam rates were 31.6% for patients of control physicians, 31.3%
for the insert, 32.8% for the outsert, 32.3% for those who received both, and 31.2% for those who received both plus
the patient reminder with the largest 95% confidence interval around any effect extending from −1.3% to 1.1%).
Conclusions: This large trial conclusively failed to demonstrate any impact of printed educational messages on
screening uptake. Despite their low cost, printed educational messages should not be routinely used in attempting to
close evidence-practice gaps relating to diabetic retinopathy screening.
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Gaps between evidence-based ideal clinical practice and
what doctors actually do can be responsible for substan-
tial harm [1,2]. For example, beta-blockers, angiotensin-
converting enzyme inhibitors, and lipid-lowering drugs
have been shown to reduce re-hospitalizations and mor-
tality following an acute myocardial infarction (AMI),
yet these drugs are underprescribed [3]. Printed educa-
tional messages (PEMs) directed to doctors may be one
way to address such gaps. PEMs have the considerable
advantage of low cost and easy dissemination, so even
small improvements may be efficiently obtained [4]. How-
ever, the evidence on their effectiveness is contradictory.
Freemantle et al. conducted a systematic review of the ef-
fects of PEMs [5]. None of the small number of included
trials found statistically significant improvements in prac-
tice, leading to the conclusion that PEMs were ineffective.
When Farmer et al. updated this review [6] using a super-
ior analytic approach (summarising observed effect sizes
instead of vote counting studies with statistically signifi-
cant effects), they observed a median absolute improve-
ment of care of 4.9% (range −8.0% to +9.6%), on par with
other much more expensive interventions like audit and
feedback, or academic outreach [7]. A further updated re-
view by Giguère et al. [8] observed smaller improvements
in care (median absolute improvement of care of 2.0%,
range 0 to +11.0%), and argued for the need for additional
primary research and further investigation of different
characteristics of PEMS in head-to-head comparisons.
These contradictory findings leave policy makers uncer-
tain about the role of PEMs, at a time when closing
evidence-to-practice gaps may offer a more cost-effective
investment of health system resources than developing
new interventions [9].
Reviews cannot overcome limitations of the primary
evidence. There are few trials of PEMs, often small in
size with methodological weaknesses (for example unit
of analysis errors in cluster randomized trials). To clar-
ify the usefulness of PEMs, large, pragmatic [7,10], and
well-designed randomized controlled trials on the effect
of PEMs on guideline adherence, conducted in real
world settings, amongst typical practitioners are needed.
The Ontario Printed Education Materials (OPEM) trial
on retinopathy screening was such a trial: a large prag-
matic cluster randomised trial powered to be able to de-
tect small effects.
In Ontario, diabetes mellitus (diabetes) affects over
15% of women and 19% of men aged 65 years and older.
Diabetic retinopathy is a common complication, affecting
about 70% of persons with type 1 diabetes and 40% of per-
sons with type 2 diabetes, and is the leading cause of pre-
ventable blindness in Canadians aged 30 to 69 [11]. Most
vision loss related to diabetic retinopathy can be prevented
through retinal screening examinations and appropriatetreatment. Early treatment has been shown to decrease
the risk of severe vision loss from proliferative diabetic ret-
inopathy by 90% and the risk of vision loss from macular
oedema by 50% [12]. Evidence-based practice guidelines
in Canada call for screening for retinopathy at the time of
diagnosis and every two years thereafter for everyone with
type 2 diabetes [13].
Under the Ontario Health Insurance Plan (OHIP)
Ontario residents have universal public health insurance,
including free at point of service access to family practi-
tioner (FP) care. Eye examinations (which include retinal
screening), performed by an optometrist, FP, or ophthal-
mologist, are also an insured service, and thus are free at
point of service to patients without any out-of-pocket
payment, for all adults aged 65 years and older and also
for those under age 65 who have been diagnosed with
diabetes.
Yet in Ontario, the observed screening rates within
the first year of diabetes diagnosis falls far below recom-
mended levels (43% and 50% for diabetes patients aged 30
to 49 and 50 to 64 respectively).
If the impact on screening uptake of PEMs was indeed
5% improvement, then at the trivial cost of a letter to
each FP, Ontario’s rate of screening and treatment, espe-
cially among younger patients, could be substantially in-
creased, averting blindness in more than 100 Ontarians
per annum [14].
We report here a trial of PEMs, evaluating their im-
pact on screening rates for diabetic retinopathy. The ob-
jective of the study was to determine whether sending a
PEM to FPs (and the format of the PEM) would affect the
likelihood that a patient visiting their doctor would receive
an eye exam within 90 days of their visit.Methods
These are presented in detail in our published proto-
col [15].
Study design and randomisation
The study was a pragmatic, factorial, cluster-randomized
controlled trial (Table 1). The study intervention was
mailed on 1 April 2005 and the follow up period extended
from 1 July 2005 to 30 June 2006. To prevent contamin-
ation (sharing of information among doctors in group
practice) we randomised at the level of the practice. FPs
were placed into practices on the basis of a shared street
address. Practices were randomly assigned to an interven-
tion group by the study statistician, using computer-
generated random numbers.
Study population
The study participants were all FPs with an active practice
in Ontario in 2003/2004. ‘Active’ practice was defined as a
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writing prescriptions for at least 100 different patients, with
at least one prescription in at least 10 of the 12 months.
The Ontario Diabetes Database was used to identify
Ontario residents diagnosed with diabetes on or before
31 March 2005. Individuals were included if they were at
least 30 years old on 31 March 2005, were alive at the
end of the follow-up period (30 June 2006), and visited
one of the target FPs within one year of the intervention
mail-out.
Patients who had an eye exam in the preceding nine
months were excluded from the study.
The printed educational materials interventions
Informed was a free, peer-reviewed, evidence-based pri-
mary care practice synopsis, written and produced by
clinical and research staff from the Institute for Clinical
Evaluative Sciences (ICES, www.ices.on.ca), and mailed
to nearly 15,000 health care providers in Ontario from
1994 to 2007.
We designed two types of PEM to address the identified
evidence-practice gap: a short, directive, evidence-based
PEM on a postcard-sized card stapled to the front page of
informed (the ‘outsert’); and a two-page insert, indistin-
guishable from the rest of informed in size and style (the
‘insert’). The insert excluded the directive statements of
the outsert but included more background, a summarised
evidence-based guideline, and references. Both were de-
veloped over three months of meetings with input from
five ICES staff with knowledge translation experience
(an internist, two family physicians, and two knowledge
translation researchers), the writing team of the informed
newsletter and a communications consultant.
We also issued a pad of take-home reminders (aimed at
patients, to remind them to make an appointment for an
eye exam), to be given to patients by their FP. Because it
was not clear whether the reminder would be any moreTable 1 Study design and number of practice groups/number
Randomized
Intervention Number of practice groups Number
1. informed only (no PEM*) 1,077 1,318
2. informed plus insert 1,066 1,305
3. informed plus outsert
a. No patient reminder notepad 535 642
b. Patient reminder notepad 536 643
4. informed plus insert & outsert
No patient reminder notepad 535 632
Patient reminder notepad 533 639
Total 4,282 5,179
*PEM: Printed Educational Message.effective than the doctor’s verbal advice, doctors rando-
mised to receive the outsert were also randomized to re-
ceive or not receive a pad of patient-aimed reminder slips.
Insert, outsert, and patient reminder were included
with the 1 April 2005 edition of informed.
Practices were randomly assigned to one of four inter-
vention groups. The two intervention groups selected to
receive an outsert were further randomly divided into
two subgroups, one of which received the patient re-
minder notepad.
Figure 1 shows the outsert and patient reminder. The
full insert is included as Additional file 1.Data sources
The following administrative data sources were used
[16]. These data sets were held securely in a linked, de-
identified form and analyzed at the Institute for Clinical
Evaluative Sciences.
1. The OHIP Claim History Database details payments
to health care professionals, including an encrypted
provider number unique to each health care
professional, an anonymous, encrypted patient
identifier unique to each patient, the service
provided, and the service date.
2. The Registered Persons Database contains basic
demographic information for each insured person.
3. The Corporate Provider Database contains limited
demographic and practice information for each
practitioner.
Finally, we used the Ontario Diabetes Database, a
validated registry of Ontario residents diagnosed with
diabetes [17].
Records from these databases were linked, using
the patient and provider identifiers, to determine whichof physicians
Included in the analysis (saw at least one patient
with diabetes during the follow-up year)








Figure 1 Interventions: the outsert and patient memo.
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cians in the year following the intervention, and whether
that individual subsequently received an eye examination.Outcomes
The primary outcome measure was whether or not an
eligible trial patient received an eye exam within 90 days
of their first FP visit during the one-year period following
the mail-out. Because the PEMs specifically addressed
the issue of insured eye exams for patients with diabetes
younger than 65 years, a secondary analysis examined the
impact of patient age on the uptake of eye exams.Power
Based on Monte Carlo simulations, assuming an intra-
cluster correlation coefficient of 0.1 [18], three patients
with diabetes per physician, and a baseline rate of screen-
ing of 36%, a trial with 1,250 practices per arm would pro-
vide over 97% power to detect an absolute increase of 5%
in the screening rate, and over 98% power to distinguish
between the effects of the combined intervention and ei-
ther alone, assuming the effect of each to be 5% and the
combined effect to be additive.Statistical analysis
Analysis was on an intention-to-treat basis. Logistic re-
gression models, estimated using generalized estimating
equations (GEE) methods to account for the clustering
of patients within physician practices, were used to esti-
mate the effect of the intervention on the likelihood of
patient screening. Two logistic regression models were
fitted: one including only the interventions (insert and/
or outsert and the patient reminders), and a second also
adjusting for patient- and physician-level covariates. All
analyses were performed using SAS version 9.1 (SAS
Institute, Cary, North Carolina). Two-tailed p-values less
than or equal to 0.05 were considered to be significant.Ethics
This study was approved by the Research Ethics Board
at Sunnybrook Health Sciences Centre.Results
Physician and patient selection
Figure 2 shows the number of physicians and patients
included in the study. Three-quarters of patients with
diabetes who met the inclusion criteria visited one of
the physicians targeted by this study during the follow
up period. However, two-thirds of these individuals
had already had an eye examination in the nine months
immediately prior to the office visit and were excluded
(Figure 2).Baseline characteristics
There were small, clinically unimportant, differences be-
tween the demographics of patients with diabetes who
paid a visit to a study physician and those who did not,
and between those who were and were not included in the
analysis (Table 2). Patients aged 65 years and older were
significantly more likely to visit a primary care doctor, and
also more likely to have received a recent eye exam (and
hence to be excluded from the analysis).
There were no meaningful physician differences among
the intervention groups (Table 3).
Analysis of intervention effects
Intervention effects are shown in Table 4. Neither the
unadjusted nor the adjusted results show any evidence
that the interventions (alone or in combination), were
effective in increasing rates of eye examination among
eligible trial patients. The widest confidence interval re-
ported in the table, an odds ratio between 0.94 and 1.04
for the insert + outsert + reminder notepad, corresponds
to a true absolute effect of the intervention lying between
a decrease in retinal screening of 1.3% and an increase
of 1.1%. Thus, the estimate of effect for the presumably
strongest ‘dose’ of intervention is of trivial clinical value, is
not statistically significantly superior compared no inter-
vention, and the confidence interval does not contain
values of clinical importance.
While the probability of having an eye examination
depended on patient age and rises sharply at age 65, there
was no indication that intervention effectiveness varied
with patient age.
The intracluster correlation coefficient was 0.024 (95%
confidence interval 0.022 to 0.025).
Discussion
In the face of the previous uncertainty about the effect-
iveness of printed educational materials in changing
physician behaviour, this study, with sufficient power to
detect even a small effect, failed to change practitioner
behaviour, as measured by retinal screening rates among
patients with diabetes. The intervention was a faithful
operationalisation of the sort of printed educational ma-
terials that are routinely used and explored both long
and short formats; this can be regarded as an evaluation
of a realistic intervention.
The effectiveness of printed educational materials de-
pends on the message being received by the physicians
at whom the PEMs were aimed, read, judged credible,
transmitted to (and acted on by) patients who might
benefit from screening. The first three steps appear likely
to have occurred: The reliability of the postal services in
Canada are such that we can be confident that the mate-
rials were successfully delivered. They are also likely to
have been read and judged credible: In 1997, The Strategic
Figure 2 Patient and physician selection: consort diagram.
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500 Ontario physicians by phone to determine readership
and recall of informed. They found that 71% of the re-
spondents recalled receiving informed and that of these,
89% found it useful or very useful and 53% read most orTable 2 Characteristics of individuals with diabetes
Patient characteristics as of April 1, 2005 Excluded f
due to no
(N = 193,6
Sex (% male) 52.9
% aged ≥66* years 39.6
Mean age in years (SD) 60.3 (14.6)
Total number of visits to a general/family physician made
by the patient during 2005/06: median (25th, 75th percentiles)
None
Years with diabetes: mean (SD) 7.1 (4.5)
†An eye examination within 9 months prior to the office visit, making the individuaevery issue (internal report, personal communication,
Dianne Kelsall, editor of informed).
It is possible that the physicians did recommend screen-
ing but did not make a referral or that patients did not
keep their ophthalmology appointments. However, givenIndividuals with diabetes who had at least one




Excluded from the analysis
due to a recent eye exam†
Patients included
in the analysis
74) (N = 373,232) (N = 179,833)
51.4 51.2
47.9 42.5
62.9 (13.9) 61.7 (13.1)
6 (3, 9) 6 (3, 10)
6.9 (4.5) 6.7 (4.4)
l ineligible for an insured complete eye examination within the next 90 days.
Table 3 Physician characteristics, by intervention group
Intervention group with number of physicians
Informed only Insert Outsert Outsert + Patient
Reminder
Insert + Outsert Insert + Outsert +
Patient reminder
All P-value‡
N = 1282 N = 1273 N = 623 N = 629 N = 620 N = 621 N = 5048
Number of patient visits 55,961 53,748 26,379 27,392 26,061 26,912 216,453
Gender (% male) 77.2 77.5 74.8 77.0 77.6 74.4 76.6 0.55
Place of training (%) 0.77
Canada 76.4 76.8 76.6 77.0 78.1 77.9 77.0
Solo practice (%) 68.4 68.7 68.1 70.3 73.4 69.9 69.5 0.27
Rural* (%) 11.9 12.3 12.5 12.1 11.8 12.9 12.2 0.99
Years since graduation:
mean (std)
26.9 (10.5) 26.5 (10.2) 26.0 (10.5) 26.3 (10.3) 26.8 (10.1) 26.4 (9.9) 26.5 (10.3) 0.62
‡P-value testing the null hypothesis that there was no difference among the intervention groups. The proportion of patients receiving an eye exam was compared
using GEE.
*A practice area was designated as rural if it was located in a geographic region with a population smaller than 10,000.
Table 4 Results
Percentage of patients obtaining retinal screening within 90 days of mail out (Crude success rate)*
Intervention Median success rate (percent) 25th and 75th percentile success
rates (percent)
P-value
Informed only (reference group) 31.0 25.0, 37.0 0.96
+ insert 30.9 25.3, 37.8
+ outsert, no reminder notepad 30.8 25.0, 37.1
+ outsert and reminder notepad 30.4 25.0, 37.5
+ insert and outsert, no reminder notepad 30.3 25.0, 37.3
+ insert and outsert and reminder notepad 30.4 25.0, 37.5
Overall 30.8 25.0, 37.5
Regression Model: Unadjusted
Intervention Odds ratio 95% confidence interval P-value
Informed only (reference group) 1.00 0.97
+ insert 1.00 0.96 to 1.03
+ outsert, no reminder notepad 0.99 0.95 to 1.05
+ outsert and reminder notepad 0.98 0.93 to 1.03
+ insert and outsert, no reminder notepad 0.99 0.94 to 1.04
+ insert and outsert and reminder notepad 0.99 0.94 to 1.04
Regression Model: Adjusted for patient and physician covariates†
Intervention Odds ratio 95% confidence interval P-value
Informed only (reference group) 1.00 0.66
+ insert 0.99 0.95 to 1.03
+ outsert, no reminder notepad 0.96 0.91 to 1.01
+ outsert and reminder notepad 0.96 0.91 to 1.02
+ insert and outsert, no reminder notepad 0.98 0.93 to 1.04
+ insert and outsert and reminder notepad 0.97 0.92 to 1.02
*In order to present the quartiles, the percentage of patients receiving an eye examination was determined for each physician, and these percentages were
summarized for each intervention group. Group practices were not taken into account for this crude analysis.
†The model was adjusted for these patient variables: age, gender, length of time diagnosed with diabetes, and whether the patient had an eye examination at
any time in the two years prior to the office visit. The model was adjusted for these physician variables: year of graduation, gender, place of training, type of
practice (solo/group), place of practice (rural/urban), and elapsed time between the mail-out and the office visit.
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diabetes and for all people aged 65 and over (in which
group eye examination among patients with diabetes
rises to 89% coverage within one year of diagnosis), it
seems unlikely that patients with diabetes would fail
to take up their physician’s recommendation simply
because they are not yet 65. Thus patient failure to
respond to the physician recommendation seems to be
an unlikely explanation for the lack of impact of our
intervention. We believe that the message was likely
received, read, and judged credible by physicians, and
would not have been ignored by patients. Yet PEMs
were not successful at improving patient screening
rates.
This suggests that PEMs simply failed to improve
physician knowledge regarding the availability of free
tests for patients with diabetes who were aged under
65; alternatively the PEMs failed to either influence the
transmission of this message to patients or to lead to
referral.
The content of our PEMs was not based on a prior as-
sessment of barriers to screening and so it is possible
that these are not the relevant barriers. Perhaps the ac-
tual barriers to improved screening lie elsewhere, with
possibilities including the organisation of screening or pa-
tient factors such as motivation or geographical access.
These potential barriers are indicated by the process study
conducted in parallel with this RCT on a subsample of
practitioners, and reported alongside [19].
This study is reliable and was conducted under realis-
tic conditions to mimic typical programme delivery. The
use of administrative data as the source of our outcome
measure allowed us to include nearly the complete popu-
lation of family practitioners and all of their eligible pa-
tients, to be able to provide a definitive result. This trial is
one of the largest published randomised trials of know-
ledge translation or implementation to date, and given its
power a false negative result is unlikely.Conclusions
This real-world study supports the conclusion that PEMs,
whether long and discursive or short and directive, and
with or without patient reminder notes, do not change
physician behaviour as measured by adherence to evi-
dence based screening recommendations for diabetic
retinopathy. These results strongly suggest that the use
of PEMs alone is not a useful strategy for closing this
evidence-practice gap, and underline the importance of
continuing to explore complementary or alternative be-
haviour change interventions. We have replicated these
results for two prescribing behaviours (in preparation)
and further replication for diagnostic and other thera-
peutic behaviours would be informative.Additional file
Additional file 1: Graphics file.
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